Name
Osaühing AstraMed
Registry code
10899846
Type
OÜ - Limited Liability Company
Status
In liquidation
Foundation date
08.01.2003 (21)
Financial year
01.01-31.12
Capital
2 555.00 €
Activity
86231 - Provision of dental treatment
0 €
-7 206 €
-
-
2 556 €
0
Submitted
No tax arrears
-282%
-282%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Liis Ernits 16.12.1955 (68) | 60% - 1 533.00 EUR | Liquidator | Direct ownership | Founder |
Mari-Liis Ernits 02.09.1979 (45) | 40% - 1 022.00 EUR | - | Direct ownership | Founder |
Katrin Paberit 15.12.1979 (44) | - | - | - | Founder |
Timo Paberit 01.02.1977 (47) | - | - | - | Founder |
2019 19.08.2020 | 2020 29.06.2021 | 2021 22.06.2022 | 2022 03.07.2023 | 2023 31.05.2024 | |
---|---|---|---|---|---|
Total Revenue | 36 187 € | 30 214 € | 33 999 € | 32 141 € | 0 € |
Net profit (loss) for the period | 236 € | -589 € | -331 € | -2 019 € | -7 206 € |
Profit Margin | 1% | -2% | -1% | -6% | - |
Current Assets | 17 038 € | 16 391 € | 15 740 € | 12 505 € | 2 556 € |
Fixed Assets | 132 € | 0 € | 0 € | 0 € | 0 € |
Total Assets | 17 170 € | 16 391 € | 15 740 € | 12 505 € | 2 556 € |
Current Liabilities | 4 211 € | 4 021 € | 3 702 € | 2 486 € | 0 € |
Non Current Liabilities | - | - | - | - | - |
Total Liabilities | - | - | - | - | - |
Share Capital | - | - | - | - | - |
Equity | 12 959 € | 12 370 € | 12 038 € | 10 019 € | 2 556 € |
Employees | 1 | 1 | 1 | 1 | 0 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2023 Q1 | - | 1 906.69 € | 1 956.17 € | - |
2022 Q4 | - | 1 911.93 € | 1 961.85 € | 2 |
2022 Q3 | - | 1 923.9 € | 1 974.14 € | 2 |
2022 Q2 | - | 1 911.93 € | 1 961.85 € | 2 |
2022 Q1 | - | 1 871.25 € | 1 917.73 € | 2 |
2021 Q4 | - | 1 850.91 € | 1 895.67 € | 2 |
2021 Q3 | - | 1 889.21 € | 1 934.92 € | 2 |
2021 Q2 | - | 1 850.91 € | 1 895.67 € | 2 |
2021 Q1 | - | 1 850.91 € | 1 895.67 € | 2 |
2020 Q4 | - | 1 850.91 € | 1 895.67 € | 2 |
2020 Q3 | - | 1 537.53 € | 1 574.15 € | 2 |
2020 Q2 | - | 1 039.65 € | 1 067.83 € | 2 |
2020 Q1 | - | 1 837.35 € | 1 880.97 € | 2 |